Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Pliant Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 144 | 1 | 136 | −7 |
| Shares | 58.1M | 639.8K | 60.2M | +2.73M (+4.7%) |
| Value | $1.05B | $11.6M | $1.04B | +$2.11M (+0.2%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 901,290 | $15.6M | 0.02% |
| Ameriprise Financial Inc | 372,127 | $6.45M | 0.00% |
| Sphera Funds Management Ltd. | 156,134 | $2.71M | 0.65% |
| Polar Asset Management Partners Inc. | 124,000 | $2.15M | 0.05% |
| Marshall Wace, LLP | 73,921 | $1.28M | 0.00% |
| Gsa Capital Partners LLP | 45,587 | $790.0K | 0.07% |
| Simplex Trading, LLC | 25,606 | $444.0K | 0.02% |
| Capstone Investment Advisors, LLC | 22,711 | $393.8K | 0.01% |
| Profund Advisors LLC | 12,405 | $215.1K | 0.01% |
| Oppenheimer & Co Inc | 12,135 | $210.4K | 0.00% |
| Bayesian Capital Management, LP | 12,000 | $208.1K | 0.02% |
| Rathbone Brothers plc | 11,700 | $202.9K | 0.00% |
| Corton Capital Inc. | 11,339 | $196.6K | 0.10% |
| Group One Trading, L.P. | 7,637 | $132.4K | 0.01% |
| Comerica Bank | 168 | $2.91K | 0.00% |
| Quadrant Capital Group LLC | 162 | $2.81K | 0.00% |
| Lindbrook Capital, LLC | 67 | $1.16K | 0.00% |
| Harbour Investments, Inc. | 25 | $434 | 0.00% |
| Cornerstone Planning Group LLC | 2 | $35 | 0.00% |
| CWM, LLC | 7 | $0 | 0.00% |
| Covestor Ltd | 7 | $0 | 0.00% |
Sold out (28)
Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (1)
Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 639,808 | $11.6M |